At a landmark meeting in La Jolla, Calif., in February 2014, 35 leading global scientists from the public and private sectors came together to discuss the creation of the Human Vaccines Project, and the primary scientific hurdles impeding the development of new vaccines . Recognizing the potential of recent technological advances in genomics, bioinformatics and systems biology, participants unanimously endorsed our vision and mission as potentially transformative for human health, and called for a decade-long, $1 billion-plus effort to decode the human immune system.
Initially incubated by the International AIDS Vaccines Initiative (IAVI) with seed funding from the Robert Wood Johnson Foundation, the Human Vaccines Project followed this first meeting with a series of workshops on specific components of its scientific and business plans. With a growing number of collaborations, the Human Vaccines Project was spun out as an independent global nonprofit organization, supported by a founding Board of Directors and an internationally recognized Scientific Steering Committee.
The Human Vaccines Project is a global nonprofit that brings together leading stakeholders across academia, industry, governments and nonprofits.
Focused on the pre-competitive immunology research space, our mission is to accelerate the development of vaccines and immunotherapies against major global infectious diseases and cancers by decoding the human immune system.
Under our consortium model, we have created a network of leading university and academic research centers that serve as our scientific hubs. These scientific hubs work collaboratively to develop and execute our scientific plan. They are bound together by innovative legal agreements, which provide for the sharing of data and materials, the rapid public release of data and shared IP with Global Access provisions to ensure benefits of the Project’s scientific breakthroughs reach populations globally.
We have engaged various organizations with significant expertise in legal, financial and science operations to support our programs. Some of our operational partners include:
Vanderbilt Institute for Clinical and Translational Research (VICTR): VICTR is one of the world’s leading clinical research coordinating centers focused on rapidly translating scientific discoveries to patient care. VICTR coordinates studies for over $300 million in scientific grants over 60 clinical sites across the US and internationally. VICTR’s staff of over 250 has extensive expertise in project management, regulatory, data management, and software development. Over the past five years, VICTR has served as the coordinating center for Clinical and Translational Science Award (CTSA), which is one the largest research networks globally focused on translational science. Last year, VICTR received a $71.6 million award, VUMC’s largest grant ever, to serve as the Data and Research Support Center for the Precision Medicine Initiative.
Global Finance Strategies (GFS): GFS is an international consulting firm that provides financial, strategic and operational counsel, capacity building and outsourcing services for NGOs, donors, governments and private sector companies. GFS is made up of highly experienced finance and operations professionals who have held leadership positions and managed highly complex funding streams in large international NGOs and companies. GFS has offices in New York, New Delhi, Rio de Janeiro, Beijing and Nairobi.
Holland & Knight: Holland & Knight is a global law firm with more than 1,200 lawyers and other professionals in 27 offices throughout the world, and provides representation in contracts, business, real estate and governmental law. The firm brings extensive experience in the Health Care & Life Sciences sector.
EPPharma Consulting: EPPharma provides small and medium sized pharmaceutical, biological, and chemical companies operational, contract, and product development guidance. EPPharma provides a wide range of contractual services including preparation and negotiation of non-disclosure, material transfer, multi-party collaboration, supply and license agreements.
We have developed a diversified and novel funding base. Donors to the Human Vaccines Project include:
- The Robert Wood Johnson Foundation
- John D. and Catherine T. MacArthur Foundation
Universities and Academic Centers
- Vanderbilt University Medical Center
- J. Craig Venter Institute
- La Jolla Institute
- The Scripps Research Institute
- U.C. San Diego
- Sanofi Pasteur
- Holland & Knight
- International AIDS Vaccine Initiative (IAVI)
- Tableau Software